The goal of this study is to conduct a prospective, longitudinal assessment of the natural clinical progression of children and adults with Synaptotagmin1-Associated Neurodevelopmental Disorder also known as Baker Gordon Syndrome (BAGOS). This will be performed by acquiring baseline measurements and developing effective outcome measures and diagnostic tools for the disorder, to prepare the healthcare system for future clinical trials.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Collection of relevant medical data (retrospective and prospective)
Timeframe: 24 months
Neurological Assessment Scale
Timeframe: 24 months
Clinical Global Impressions Scale - Practitioner
Timeframe: 24 months
Pediatric Evaluation of Disability Inventory
Timeframe: 24 months
Pediatric Evaluation of Disability Inventory Computer Adaptive Test (PEDI-CAT)
Timeframe: 24 months